Genmab — April 2018
-
God morgen

-
I am not sure if anyone mentioned yet that Daratumumab got a positive opinion for Orphan product designation for treatment of AL amyloidosis ? http://www.ema.europa.eu/docs/en_GB/document_library/Committee_meeting_report/2018/04/WC500247972.pdf
-
The 2018 'ASCO Educational Book' -
https://am.asco.org/sites/am.asco.org/files/2018-AM-Educational-Book.pdf (big file!) -
Fra 19/4 ydes refusion i Italien til D-Rd eller D-Vd i anden linje. http://www.agenziafarmaco.gov.it/content/pubblicazione-schede-di-monitoraggio-registro-darzalex-19042018
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind